• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷脱氨酶水平高的结核性与恶性胸腔积液的实验室及影像学鉴别

Laboratory and radiological discrimination between tuberculous and malignant pleural effusions with high adenosine deaminase levels.

作者信息

Lee Jaehee, Park Ji Eun, Choi Sun Ha, Seo Hyewon, Lee Sang Yub, Lim Jae Kwang, Yoo Seung Soo, Lee Shin Yup, Cha Seung Ick, Park Jae Yong, Kim Chang Ho

机构信息

Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.

Department of Radiology, School of Medicine, Kyungpook National University, Daegu, Korea.

出版信息

Korean J Intern Med. 2022 Jan;37(1):137-145. doi: 10.3904/kjim.2020.246. Epub 2021 Jul 15.

DOI:10.3904/kjim.2020.246
PMID:33045810
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8747933/
Abstract

BACKGROUND/AIMS: Pleural fluid adenosine deaminase (ADA) levels are useful in discriminating tuberculous pleural effusions (TPEs) from malignant pleural effusions (MPEs). However, some patients with MPE exhibit high-ADA levels, which may mimic TPEs. There is limited data regarding the differential diagnosis between high-ADA MPE and high-ADA TPE. This study aimed to identify the predictors for distinguishing high-ADA MPEs from high-ADA TPEs.

METHODS

Patients with TPE and MPE with pleural fluid ADA levels ≥ 40 IU/L were included in this study. Clinical, laboratory, and radiological data were compared between the two groups. Independent predictors and their diagnostic performance for high-ADA MPEs were evaluated using multivariate logistic regression analysis and receiver operating characteristic curve.

RESULTS

A total of 200 patients (high-ADA MPE, n = 30, and high-ADA TPE, n = 170) were retrospectively included. In the multivariate analysis, pleural fluid ADA, pleural fluid carcinoembryonic antigen (CEA), and pleural nodularity were independent discriminators between high-ADA MPE and high-ADA TPE groups. Using pleural ADA level of 40 to 56 IU/L (3 points), pleural CEA level ≥ 6 ng/mL (6 points), and presence of pleural nodularity (3 points) for predicting high-ADA MPEs, a sum score ≥ 6 points yielded a sensitivity of 90%, specificity of 96%, positive predictive value of 82%, negative predictive value of 98%, and area under the receiver operating characteristic curve of 0.965.

CONCLUSION

A scoring system using three parameters may be helpful in guiding the differential diagnosis between high-ADA MPEs and high-ADA TPEs.

摘要

背景/目的:胸腔积液腺苷脱氨酶(ADA)水平有助于鉴别结核性胸腔积液(TPE)和恶性胸腔积液(MPE)。然而,一些MPE患者的ADA水平较高,可能会与TPE相似。关于高ADA水平的MPE和高ADA水平的TPE之间的鉴别诊断数据有限。本研究旨在确定区分高ADA水平的MPE和高ADA水平的TPE的预测因素。

方法

本研究纳入了胸腔积液ADA水平≥40 IU/L的TPE和MPE患者。比较两组的临床、实验室和影像学数据。使用多因素逻辑回归分析和受试者工作特征曲线评估高ADA水平MPE的独立预测因素及其诊断性能。

结果

共回顾性纳入200例患者(高ADA水平MPE,n = 30;高ADA水平TPE,n = 170)。在多因素分析中,胸腔积液ADA、胸腔积液癌胚抗原(CEA)和胸膜结节是高ADA水平MPE组和高ADA水平TPE组之间的独立鉴别因素。使用胸腔ADA水平40至56 IU/L(3分)、胸腔CEA水平≥6 ng/mL(6分)和胸膜结节的存在(3分)来预测高ADA水平的MPE,总分≥6分的敏感度为90%,特异度为96%,阳性预测值为82%,阴性预测值为98%,受试者工作特征曲线下面积为0.965。

结论

使用三个参数的评分系统可能有助于指导高ADA水平的MPE和高ADA水平的TPE之间的鉴别诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1172/8747933/0e075f5e8392/kjim-2020-246f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1172/8747933/aae553d83d1b/kjim-2020-246f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1172/8747933/e99e74acb90f/kjim-2020-246f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1172/8747933/0e075f5e8392/kjim-2020-246f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1172/8747933/aae553d83d1b/kjim-2020-246f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1172/8747933/e99e74acb90f/kjim-2020-246f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1172/8747933/0e075f5e8392/kjim-2020-246f3.jpg

相似文献

1
Laboratory and radiological discrimination between tuberculous and malignant pleural effusions with high adenosine deaminase levels.腺苷脱氨酶水平高的结核性与恶性胸腔积液的实验室及影像学鉴别
Korean J Intern Med. 2022 Jan;37(1):137-145. doi: 10.3904/kjim.2020.246. Epub 2021 Jul 15.
2
Combined detections of interleukin 27, interferon-γ, and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy.胸腔积液中白细胞介素 27、干扰素-γ 和腺苷脱氨酶联合检测对结核性胸膜炎的诊断价值。
Chin Med J (Engl). 2013;126(17):3215-21.
3
Predictive role of adenosine deaminase for differential diagnosis of tuberculosis and malignant pleural effusion in Turkey.腺苷脱氨酶在土耳其结核与恶性胸腔积液鉴别诊断中的预测作用
Asian Pac J Cancer Prev. 2011;12(2):419-23.
4
Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel.结核性和恶性胸腔积液的鉴别诊断:Th1/Th2 细胞因子谱、肿瘤标志物谱和化学谱的比较。
Scand J Clin Lab Invest. 2020 Jul;80(4):265-270. doi: 10.1080/00365513.2020.1728784. Epub 2020 Feb 28.
5
A combination of the QuantiFERON-TB Gold In-Tube assay and the detection of adenosine deaminase improves the diagnosis of tuberculous pleural effusion.结核分枝杆菌伽马干扰素释放试验联合腺苷脱氨酶检测对结核性胸腔积液的诊断价值。
Emerg Microbes Infect. 2016 Aug 3;5(8):e83. doi: 10.1038/emi.2016.80.
6
Adenosine deaminase-based measurement in the differential diagnosis of pleural effusion: a multicenter retrospective study.基于腺苷脱氨酶的胸腔积液鉴别诊断测量:一项多中心回顾性研究。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231155747. doi: 10.1177/17534666231155747.
7
Clinical significance of pleural fluid lactate dehydrogenase/adenosine deaminase ratio in the diagnosis of tuberculous pleural effusion.胸腔积液乳酸脱氢酶/腺苷脱氨酶比值对结核性胸腔积液诊断的临床意义。
BMC Pulm Med. 2024 May 15;24(1):241. doi: 10.1186/s12890-024-03055-0.
8
Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.胸腔干扰素-γ释放试验联合生物标志物可有效鉴别结核性胸腔积液和恶性胸腔积液。
BMC Infect Dis. 2019 Jan 16;19(1):55. doi: 10.1186/s12879-018-3654-z.
9
Differential diagnosis of tuberculous and malignant pleural effusions: what is the role of adenosine deaminase?结核性与恶性胸腔积液的鉴别诊断:腺苷脱氨酶的作用是什么?
Lung. 2008 Jul-Aug;186(4):233-240. doi: 10.1007/s00408-008-9085-7. Epub 2008 Mar 21.
10
Diagnostic value of interleukin 21 and carcinoembryonic antigen levels in malignant pleural effusions.白细胞介素21和癌胚抗原水平在恶性胸腔积液中的诊断价值
Asian Pac J Cancer Prev. 2012;13(7):3495-9. doi: 10.7314/apjcp.2012.13.7.3495.

引用本文的文献

1
Diagnostic Efficacy of C-Reactive Protein in Differentiating Various Causes of Exudative Pleural Effusion: Disease Research Should Not Be Exclusive to the Wealthy.C反应蛋白在鉴别渗出性胸腔积液各种病因中的诊断效能:疾病研究不应只为富人服务。
Adv Respir Med. 2025 Aug 5;93(4):29. doi: 10.3390/arm93040029.
2
Tuberculous and Malignant Pleural Effusions With Adenosine Deaminase Levels of 40-70 IU/L: Trends in New Cases Over Time and Differentiation Between Groups.腺苷脱氨酶水平为40 - 70 IU/L的结核性和恶性胸腔积液:新发病例随时间的变化趋势及组间鉴别
J Korean Med Sci. 2025 Apr 7;40(13):e35. doi: 10.3346/jkms.2025.40.e35.
3

本文引用的文献

1
Contemporary approach to the patient with malignant pleural effusion complicating lung cancer.肺癌合并恶性胸腔积液患者的现代治疗方法。
Ann Transl Med. 2019 Aug;7(15):352. doi: 10.21037/atm.2019.03.61.
2
Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion.胸水与血清中癌胚抗原比值对恶性胸腔积液的诊断价值
Ther Adv Med Oncol. 2019 May 22;11:1758835919850341. doi: 10.1177/1758835919850341. eCollection 2019.
3
Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Etiology of exudative pleural effusion among adults: differentiating between tuberculous and other causes, a multicenter prospective cohort study.
成人渗出性胸腔积液的病因:区分结核性与其他病因,一项多中心前瞻性队列研究。
IJID Reg. 2024 Aug 14;12:100425. doi: 10.1016/j.ijregi.2024.100425. eCollection 2024 Sep.
4
Clinical significance of pleural fluid lactate dehydrogenase/adenosine deaminase ratio in the diagnosis of tuberculous pleural effusion.胸腔积液乳酸脱氢酶/腺苷脱氨酶比值对结核性胸腔积液诊断的临床意义。
BMC Pulm Med. 2024 May 15;24(1):241. doi: 10.1186/s12890-024-03055-0.
5
Added value of 40 keV virtual monoenergetic images for diagnosing malignant pleural effusion on chest CT.40keV 虚拟单能量图像在胸部 CT 诊断恶性胸腔积液中的附加价值。
Jpn J Radiol. 2024 Aug;42(8):862-871. doi: 10.1007/s11604-024-01571-x. Epub 2024 May 3.
6
Features which discriminate between tuberculosis and haematologic malignancy as the cause of pleural effusions with high adenosine deaminase.区分胸腔积液中腺苷脱氨酶升高的病因是结核病还是血液系统恶性肿瘤的特征。
Respir Res. 2024 Jan 4;25(1):17. doi: 10.1186/s12931-023-02645-6.
7
ADA as main biochemical marker in patients with tuberculous effusion.ADA作为结核性胸腔积液患者的主要生化标志物。
J Med Biochem. 2023 Oct 27;42(4):722-726. doi: 10.5937/jomb0-44018.
8
Differentiating between tuberculous and non-tuberculous pleural effusions using the pleural fluid ratio of 10× adenosine deaminase/lactate dehydrogenase.利用胸腔积液中10倍腺苷脱氨酶与乳酸脱氢酶的比值鉴别结核性和非结核性胸腔积液。
J Thorac Dis. 2023 May 30;15(5):2627-2635. doi: 10.21037/jtd-23-383. Epub 2023 May 29.
9
Development and Validation of a Scoring System for Early Diagnosis of Malignant Pleural Effusion Based on a Nomogram.基于列线图的恶性胸腔积液早期诊断评分系统的开发与验证
Front Oncol. 2021 Dec 7;11:775079. doi: 10.3389/fonc.2021.775079. eCollection 2021.
胸腔疾病诊断中的生物标志物:2018 年更新。
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618808660. doi: 10.1177/1753466618808660.
4
Misdiagnosis of primary pleural DLBCL as tuberculosis: A case report and literature review.原发性胸膜弥漫大B细胞淋巴瘤误诊为肺结核:一例报告及文献复习
Mol Clin Oncol. 2018 Jun;8(6):729-732. doi: 10.3892/mco.2018.1601. Epub 2018 Apr 2.
5
Pleural fluid adenosine deaminase/serum C-reactive protein ratio for the differentiation of tuberculous and parapneumonic effusions with neutrophilic predominance and high adenosine deaminase levels.用于鉴别以中性粒细胞为主且腺苷脱氨酶水平高的结核性和类肺炎性胸腔积液的胸腔积液腺苷脱氨酶/血清C反应蛋白比值
Infection. 2017 Feb;45(1):59-65. doi: 10.1007/s15010-016-0928-5. Epub 2016 Aug 3.
6
Pleural Fluid Adenosine Deaminase (ADA) Predicts Survival in Patients with Malignant Pleural Effusion.胸腔积液腺苷脱氨酶(ADA)可预测恶性胸腔积液患者的生存率。
Lung. 2016 Aug;194(4):681-6. doi: 10.1007/s00408-016-9891-2. Epub 2016 Jun 14.
7
Predicting malignant and tuberculous pleural effusions through demographics and pleural fluid analysis of patients.通过患者的人口统计学特征和胸腔积液分析预测恶性和结核性胸腔积液。
Clin Respir J. 2015 Apr;9(2):203-13. doi: 10.1111/crj.12125. Epub 2014 Mar 20.
8
Derivation and validation of a CT scan scoring system for discriminating malignant from benign pleural effusions.用于鉴别恶性与良性胸腔积液的CT扫描评分系统的推导与验证
Chest. 2015 Feb;147(2):513-519. doi: 10.1378/chest.14-0013.
9
Role of CT in assessing pleural malignancy prior to thoracoscopy.CT 在胸腔镜检查前评估胸膜恶性肿瘤中的作用。
Thorax. 2015 Feb;70(2):192-3. doi: 10.1136/thoraxjnl-2014-206054. Epub 2014 Jul 30.
10
CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.恶性胸腔积液中的癌胚抗原(CEA)、甲胎蛋白(AFP)、癌抗原125(CA125)、癌抗原153(CA153)和癌抗原199(CA199)可预测病因。
Asian Pac J Cancer Prev. 2014;15(1):363-8. doi: 10.7314/apjcp.2014.15.1.363.